{"nctId":"NCT00212355","briefTitle":"Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.","startDateStruct":{"date":"2005-03"},"conditions":["Wilson's Disease"],"count":37,"armGroups":[{"label":"NPC-02","type":"EXPERIMENTAL","interventionNames":["Drug: NPC-02"]}],"interventions":[{"name":"NPC-02","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Wilson's disease(adult, infant, pregnant woman)\n\nExclusion Criteria:\n\n* Acute hepatitis\n* Malignant tumor","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Year","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Safety and Efficacy","description":"Number of patients who have at least one adverse events. ALT Change","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":37},"commonTop":["Lipase increased","Nasopharyngitis","Blood iron decreased","Blood amylase increased","Blood urine present"]}}}